ETAHX
Eventide Healthcare & Life Sciences A
1W: -1.1%
1M: -10.0%
3M: -8.7%
YTD: +4.3%
1Y: +30.5%
3Y: +60.8%
5Y: +17.6%
$51.73
-0.19 (-0.37%)
Weekly Expected Move ±3.0%
$49
$50
$52
$53
$55
Portfolio Health Summary
IS Overall Score
36.8
★★★★★
Altman Z-Score
25.14
Safe
Weight Coverage
85%
of portfolio analyzed
Holdings Matched
58
with fundamental data
InsiderStreet Scorecard
★★★★★
36.8
Top Holdings: Score Breakdown
Risk & Quality Signals
Altman Z-Score
25.14
Safe Zone (>2.99)
Piotroski F-Score
3.3 / 9
Weak
Beneish M-Score
21.78
Possible Manipulator
Credit Score
—
Earnings Quality
48.1 / 100
Portfolio Valuation
P/E
87.78x
P/B
0.95x
P/S
15.34x
EV/EBITDA
95.69x
EV/Revenue
15.30x
P/FCF
121.58x
P/OCF
101.07x
PEG
4.68x
Earnings Yield
1.14%
FCF Yield
0.82%
OCF Yield
0.99%
Median P/E
-13.40x
Growth & Shareholder Returns
Year-over-Year Growth
Revenue
+51.4%
Net Income
-30.1%
EPS
-17.7%
FCF
-26.8%
EBITDA
-29.2%
Op. Income
—
Compound Growth Rates
Rev CAGR 3Y
+56.4%
Rev CAGR 5Y
+44.6%
EPS CAGR 3Y
+18.8%
EPS CAGR 5Y
+17.8%
FCF CAGR 3Y
+29.5%
FCF CAGR 5Y
+117.2%
EBITDA CAGR 3Y
+33.8%
EBITDA CAGR 5Y
+26.2%
Payout Ratio
0.00%
Buyback Yield
0.26%
Dividend Yield
0.00%
Total Shareholder Return
-7.72%
Earnings Stability
Monte Carlo Price Simulation
Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1800 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.
Current Price
$51.92
Median 1Y
$54.14
5th Pctile
$34.39
95th Pctile
$85.39
Ann. Volatility
29.2%
25th–75th percentile
5th–95th percentile
Median path
Historical
All Ratios & Metrics
Valuation (12)
| Metric | Value |
|---|---|
| Portfolio P/E | 87.78 |
| Portfolio P/B | 0.95 |
| Portfolio P/S | 15.34 |
| EV/EBITDA | 95.69 |
| EV/Revenue | 15.30 |
| P/FCF | 121.58 |
| P/OCF | 101.07 |
| PEG | 4.68 |
| Earnings Yield | 1.14% |
| FCF Yield | 0.82% |
| OCF Yield | 0.99% |
| Median P/E | -13.40 |
Profitability & Returns (9)
| Metric | Value |
|---|---|
| Gross Margin | 78.21% |
| Operating Margin | -39.99% |
| Net Margin | -42.47% |
| FCF Margin | -34.53% |
| ROE | -4.90% |
| ROA | -2.61% |
| ROIC | -3.52% |
| ROCE | — |
| Asset Turnover | — |
Leverage & Solvency (6)
| Metric | Value |
|---|---|
| Debt/Equity | 0.06 |
| Debt/Assets | 0.03 |
| Net Debt/EBITDA | -52.13 |
| Interest Coverage | -12.31 |
| Current Ratio | 1.71 |
| Quick Ratio | 1.70 |
Efficiency (4)
| Metric | Value |
|---|---|
| Asset Turnover | — |
| Inventory Turnover | — |
| Receivables Turnover | — |
| Payables Turnover | — |
Growth — YoY (6)
| Metric | Value |
|---|---|
| Revenue Growth | 51.41% |
| Net Income Growth | -30.12% |
| EPS Growth | -17.66% |
| FCF Growth | -26.83% |
| EBITDA Growth | -29.23% |
| Op. Income Growth | — |
Growth — CAGR (16)
| Metric | Value |
|---|---|
| Revenue CAGR 3Y | 56.41% |
| Revenue CAGR 5Y | 44.62% |
| Revenue CAGR 10Y | — |
| EPS CAGR 3Y | 18.76% |
| EPS CAGR 5Y | 17.78% |
| EPS CAGR 10Y | — |
| FCF CAGR 3Y | 29.48% |
| FCF CAGR 5Y | 117.22% |
| FCF CAGR 10Y | — |
| EBITDA CAGR 3Y | 33.78% |
| EBITDA CAGR 5Y | 26.15% |
| EBITDA CAGR 10Y | — |
| Net Income CAGR 3Y | 16.74% |
| Net Income CAGR 5Y | 16.24% |
| Op. Income CAGR 3Y | — |
| Op. Income CAGR 5Y | — |
Quality Scores (13)
| Metric | Value |
|---|---|
| IS Overall | 36.8 |
| IS Profitability | 25.3 |
| IS Balance Sheet | 45.4 |
| IS Earnings Quality | 48.1 |
| IS Growth | 53.2 |
| IS Value | 33.0 |
| IS Momentum | 52.2 |
| IS Safety | 80.0 |
| IS Quality | 40.2 |
| Altman Z-Score | 25.14 |
| Piotroski F-Score | 3.28 |
| Beneish M-Score | 21.78 |
| Credit Score | — |
Dividends & Payout (4)
| Metric | Value |
|---|---|
| Dividend Yield | 0.00% |
| Payout Ratio | 0.00% |
| Buyback Yield | 0.26% |
| Total Shareholder Return | -7.72% |
Growth Stability (4)
| Metric | Value |
|---|---|
| Revenue Stability | 0.691 |
| Earnings Stability | 0.598 |
| Earnings Persistence | 0.688 |
| Margin Stability | 0.619 |
Medians (3)
| Metric | Value |
|---|---|
| Median P/E | -13.40 |
| Median P/B | 4.42 |
| Median Dividend Yield | — |
Coverage Meta (3)
| Metric | Value |
|---|---|
| Weight Coverage % | 85.11% |
| Holdings Matched | 58 |
| Total Holdings | 58 |